Luigi Mangione’s federal guilty plea in connection with the killing of UnitedHealthcare CEO Brian Thompson has brought one of America’s most closely watched criminal cases back into the spotlight. But shortly after Mangione admitted his role in federal court, NYPD Commissioner Jessica Tisch turned her attention beyond the defendant himself, delivering an unusually direct warning to people who have celebrated him online: “Violence is not a cause, murder is not a message, and a killer is not a hero.”

Mangione, 28, pleaded guilty on August 14 to two federal charges: interstate stalking resulting in death and stalking through the use of interstate facilities resulting in death. The charges stem from the December 4, 2024 shooting of Thompson in Manhattan, an attack that shocked the corporate world and quickly became much more than a conventional homicide investigation.

Thompson was the CEO of UnitedHealthcare, one of the largest health insurers in the United States. His killing generated an extraordinary and deeply polarized reaction. While many condemned the violence, others used the case to express anger over health insurance costs, denied claims and frustrations with the American healthcare system. Mangione eventually attracted a group of vocal supporters, sometimes referred to online as “Mangionistas,” who portrayed him as a symbol of resistance against the health insurance industry.

For Tisch, however, frustration with an industry could never justify what happened to Thompson.

“Luigi Mangione carried out a ruthless act of violence that shocked this city, and today’s guilty plea is an important moment of accountability for this heinous crime,” the commissioner said following the plea.

Her strongest words were aimed directly at those who have idolized Mangione. The intense fascination surrounding the defendant has followed the case for nearly two years, with supporters discussing him across social media, gathering around court appearances and making harsh comments about Thompson. Reports about some supporters even raised concerns about discussions surrounding possible interference with the jury process before Mangione entered his federal plea.

The unusual public reaction became apparent almost immediately after Thompson’s death. Anger toward health insurance companies was already widespread, and the killing became a flashpoint for broader arguments about the American healthcare system. An Emerson College poll conducted in December 2024 found a striking generational divide, with 41% of respondents between 18 and 29 describing the killer’s actions as acceptable.

But inside the courtroom, the focus was not on internet debates or political symbolism. It was on Mangione’s own actions.

During his allocution, Mangione described suffering from debilitating back pain for years and struggling to navigate the health insurance system. He also explained how he obtained information connected to the conference Thompson was attending. According to his account, he contacted UnitedHealthcare while posing as an investor and received information much more quickly than he felt he had been able to obtain assistance as a patient.

Those frustrations became part of his explanation for the events leading to Thompson’s killing, but they do not erase the criminal consequences he now faces.

The federal guilty plea represents a major development, yet it does not necessarily mean Mangione’s legal battle is approaching its end. His potential sentence remains a major point of contention.

Federal prosecutors indicated that they still intend to pursue life imprisonment. Judge Margaret Garnett, however, said sentencing guidelines presented by prosecutors appeared to place Mangione in a range of approximately 292 to 365 months behind bars—roughly 24 to 30 years. His eventual punishment will therefore become another closely watched stage of the case.

And there is an entirely separate legal fight unfolding in New York State court.

Mangione has also been charged with murder at the state level and has pleaded not guilty to those charges. His state trial is scheduled to begin on September 8. Immediately after the federal guilty plea, his defense attorneys filed motions seeking dismissal of the state charges on double-jeopardy grounds.

The argument raises a significant question: after Mangione admitted guilt to federal offenses connected to Thompson’s death, can New York still prosecute him separately for murder?

The Manhattan District Attorney’s Office has made clear that prosecutors intend to fight the defense request, saying the state is prepared to litigate the motions. That means the courtroom battle could soon shift from the facts surrounding Thompson’s death to complicated constitutional questions about whether the state prosecution can continue.

For now, Mangione remains detained at the Metropolitan Detention Center in Brooklyn as those proceedings move forward.

Yet the legal questions are only one reason this case continues to command attention. The larger controversy concerns what Mangione has come to represent to different groups of Americans.

To prosecutors and law enforcement officials, this is fundamentally the story of a man who stalked another person and caused his death. To some of Mangione’s supporters, however, the case became connected to their anger toward health insurers and a system they believe has failed patients. Those competing interpretations have transformed the proceedings into a cultural and political argument far larger than the courtroom itself.

Tisch’s statement was an attempt to draw a firm boundary between criticizing a system and celebrating violence against an individual.

Americans can debate insurance companies. They can criticize healthcare executives, demand political reforms, protest denied claims and push lawmakers to change the system. What law enforcement officials reject is the idea that killing someone can become a legitimate extension of those grievances.

That distinction has become particularly important because Mangione’s image has taken on a life of its own online. The fascination has at times focused not merely on his alleged motives or the healthcare debate but on Mangione personally, creating a strange form of celebrity around a defendant accused of one of the most notorious killings in recent New York history.

For Thompson’s family, however, the case is not an online symbol or political argument. A husband, father and family member was killed.

That human reality risks becoming obscured when a criminal case becomes intertwined with broader frustrations about healthcare, wealth and corporate power. Tisch’s message therefore appears designed to redirect attention toward the central fact at the heart of the prosecution: dissatisfaction with an institution does not make violence against an individual acceptable.

Mangione’s guilty plea has answered one major question about his federal case, but it has opened several others.

How much prison time will he ultimately receive? Will federal prosecutors succeed in pushing for a sentence harsher than the guideline range discussed in court? Will his attorneys convince a New York judge that the state murder prosecution should be dismissed? Or will Mangione soon face another courtroom and another potentially devastating verdict?

The September 8 state trial could provide the next major turning point. Before that happens, however, judges will have to confront the defense’s double-jeopardy challenge—an argument that could dramatically reshape what comes next.

Nearly two years after Brian Thompson was shot, the case remains about far more than a single guilty plea. It has become a collision between criminal justice, public anger over healthcare, online celebrity culture and the limits of political protest.

Jessica Tisch’s message attempted to cut through all of that controversy with one uncompromising distinction: people are free to demand change, but violence cannot be transformed into heroism simply because the victim represented an unpopular industry.

Mangione has now admitted responsibility for serious federal crimes connected to Thompson’s death. But with another trial approaching and his attorneys launching a new constitutional challenge, the most consequential chapter of this extraordinary case may still be ahead.